Once the mice developed palpable tumours, they were treated i.p. with the MEK inhibitor U0126 or control vehicle; 5 h later the mice received i.p. 5-ALA, and tumour fluorescence was evaluated 2 h later (Fig. 3). Here, MAP2K7 is linked to neoplasm.